Skip to main content
. 2024 Sep 15;16(9):4728–4740. doi: 10.62347/PRDN7778

Table 4.

Comparison of inflammatory factors before and after treatment (±s)

Group IL-6 (pg/ml) CRP (mg/L) TNF-α (ng/L) IL-1β (ng/L) PGE2 (μg/L)





Before treatment After treatment Before treatment After treatment Before treatment After treatment Before treatment After treatment Before treatment After treatment
Study Group B (n=40) 53.28±6.36 32.52±4.78 2.31±0.42 1.57±0.20 25.26±3.77 10.34±1.78 86.31±17.56 50.12±10.22 366.54±27.68 226.78±19.67
Study Group A (n=40) 53.42±6.71 37.45±5.23 2.28±0.37 1.98±0.22 25.34±3.68 17.25±2.13 87.26±17.88 56.92±12.81 364.31±29.60 255.74±23.55
Control group (n=40) 3.59±1.12a,b / 1.26±0.18a,b / 0.91±0.12a,b / 4.31±1.26a,b / 43.78±10.57a,b /
T/F 1139.282 4.764 120.507 8.818 859.278 15.783 426.776 2.630 2364.750 6.032
P < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.010 < 0.001 < 0.001

Note: IL-6: Interleukin-6, CRP: C-reactive protein, TNF-α: tumor necrosis factor alpha, IL-1β: Interleukin-1β, PEG2: prostaglandin E2.

a

P < 0.05, compare with group B;

b

P < 0.05, compare with group A.